Cas9 RNP targeting cis-regulatory elements in lymphocytes
Cas9 RNP targeting cis-regulatory elements in lymphocytes
批准号:
10630567
负责人:
Karl Mark Ansel
金额:
$7.84万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2024-06-30
关键词:
AchievementAnimal ModelAsthmaB-LymphocytesBase PairingBindingBiochemicalBioinformaticsBiologicalCRISPR libraryCRISPR/Cas technologyCell Culture TechniquesCell physiologyClustered Regularly Interspaced Short Palindromic RepeatsCodeComplexDevelopmentDoctor of PhilosophyFamilyGene ExpressionGenesGeneticGenomicsGoalsGuide RNAHumanHypersensitivityImmuneImmune responseIndividualInvestigationLaboratoriesLibrariesLymphocyteLymphocyte FunctionMediatingMessenger RNAMicroRNAsModelingMolecularMusNucleic Acid Regulatory SequencesOpen Reading FramesPathogenesisPathway interactionsPlayProteinsRegulationRegulator GenesRegulatory ElementResearchResearch PersonnelRoleSomatic CellSpecialistSpecificitySystemT-LymphocyteTechnical ExpertiseTestingTransfectionTranslationsWorkbasecareerdesignexperienceexperimental studygene discoverygene networkgenome editingimmunopathologymRNA Transcript Degradationnext generationnovelparent grantpreventprogramsskillssuccesstool
中文摘要
项目摘要
用于基因组编辑的CRISPR工具彻底改变并加速了编码的功能性询问
在模型动物系统和人体细胞中的基因,包括初级淋巴细胞,
在过敏和哮喘的免疫病理学中的作用。我们建议调整和优化这些用于miRNA的工具-
定向路径发现首先,将为我们现有的目标创建合并的逆转录病毒CRISPR文库,
根据经验鉴定了miR-29,一种在T细胞和B细胞中具有关键功能的miRNA。二是
将下一代基于转染的CRISPR系统扩展到靶向顺式调控序列,
编码蛋白质,但介导miRNA和靶mRNA之间的调节相互作用。成功在这些
目标将使详细的机制分析的miRNA:目标网络,管理免疫反应,
哮喘和过敏。该提案的第二个重要目标是支持职业和科学
塞莱斯特加尔萨的发展,一个学士后研究员获得研究经验,作为一个大三
安塞尔实验室的专家拟议中的实验建立在她在安塞尔实验室学到的技能之上,
并将为她提供机会,以发展研究叙述和科学成就,
申请明年的博士课程。
英文摘要
Project Summary
CRISPR tools for genome editing have revolutionized and accelerated the functional interrogation of coding
genes in model animal systems and in human somatic cells, including primary lymphocytes that play critical
roles in the immunopathology of allergy and asthma. We propose to adapt and optimize these tools for miRNA-
directed pathway discovery. First, will create pooled retroviral CRISPR libraries for targets that we have
empirically identified for miR-29, a miRNA with critical functions in both T cells and B cells. Second, we will
extend next generation transfection-based CRISPR systems to target cis-regulatory sequences that do not
code for protein, but mediate regulatory interactions between miRNAs and target mRNAs. Success in these
aims will enable detailed mechanistic analysis of miRNA:target networks that govern immune responses in
asthma and allergy. A second important goal of this proposal is to support the career and scientific
development of Celeste Garza, a post-baccalaureate researcher gaining research experience as a junior
specialist in the Ansel laboratory. The proposed experiments build on skills she has learned in the Ansel lab,
and will provide the opportunity for her to develop a research narrative and scientific achievements as prepares
to apply for PhD programs in the coming year.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predoctrol Training in Biomedical Sciences
-
批准号:10192762
-
项目类别:
-
资助金额:$56.54万
-
财政年份:2020
-
负责人:Karl Mark Ansel
-
依托单位:
Restorative practice in repairing harm and promoting safe and inclusive practices in the laboratory.
-
批准号:10393434
-
项目类别:
-
资助金额:$8.64万
-
财政年份:2020
-
负责人:Karl Mark Ansel
-
依托单位:
MicroRNA Networks in self-sustaining type 2 airway niches in asthma
-
批准号:10226877
-
项目类别:
-
资助金额:$54.26万
-
财政年份:2012
-
负责人:Karl Mark Ansel
-
依托单位:
MicroRNA Networks in self-sustaining type 2 airway niches in asthma
-
批准号:10006352
-
项目类别:
-
资助金额:$54.26万
-
财政年份:2012
-
负责人:Karl Mark Ansel
-
依托单位:
MicroRNA Networks in self-sustaining type 2 airway niches in asthma
-
批准号:10681275
-
项目类别:
-
资助金额:$54.26万
-
财政年份:2012
-
负责人:Karl Mark Ansel
-
依托单位:
MicroRNA Networks in self-sustaining type 2 airway niches in asthma
-
批准号:10472538
-
项目类别:
-
资助金额:$54.26万
-
财政年份:2012
-
负责人:Karl Mark Ansel
-
依托单位:
Role of miRNAs in Th2-Driven inflammation in Asthma
-
批准号:8309235
-
项目类别:
-
资助金额:$18.01万
-
财政年份:2011
-
负责人:Karl Mark Ansel
-
依托单位:
MicroRNA directed pathway discovery in allergy and asthma
-
批准号:10840232
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2011
-
负责人:Karl Mark Ansel
-
依托单位:
MicroRNA directed pathway discovery in allergy and asthma
-
批准号:10433928
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2011
-
负责人:Karl Mark Ansel
-
依托单位:
Role of miRNAs in Th2-Driven inflammation in Asthma
-
批准号:8870413
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2011
-
负责人:Karl Mark Ansel
-
依托单位:
Role of miRNAs in Th2-Driven inflammation in Asthma
-
批准号:8697120
-
项目类别:
-
资助金额:$27.38万
-
财政年份:2011
-
负责人:Karl Mark Ansel
-
依托单位:
MicroRNA directed pathway discovery in allergy and asthma
-
批准号:10671457
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2011
-
负责人:Karl Mark Ansel
-
依托单位:
Role of miRNAs in Th2-Driven inflammation in Asthma
-
批准号:8160298
-
项目类别:
-
资助金额:$54.09万
-
财政年份:2011
-
负责人:Karl Mark Ansel
-
依托单位:
Role of miRNAs in Th2-Driven inflammation in Asthma
-
批准号:8512777
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2011
-
负责人:Karl Mark Ansel
-
依托单位:
MicroRNA directed pathway discovery in allergy and asthma
-
批准号:10206229
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2011
-
负责人:Karl Mark Ansel
-
依托单位:
Regulation of miRNA expression during helper T cell differentiation
-
批准号:8125523
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2010
-
负责人:Karl Mark Ansel
-
依托单位:
海外基金